pharma · Influenza · Celiac Disease · BRNS
Barinthus Biotherapeutics
Barinthus Biotherapeutics plc.
Barinthus Biotherapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Harwell, GB HQ
2016 Founded
36 Employees
Public company Type
BRNS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Harwell, GB
- Founded
- 2016
- Employees
- 36
- Programs
- 9
- Drugs
- 5
- Patents
- 0
Barinthus Biotherapeutics patents
0 pharmaceutical patents indexed for Barinthus Biotherapeutics. 0 expire within 24 months.
Barinthus Biotherapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Barinthus Biotherapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Barinthus Biotherapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.